1. Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ,
Vaduganathan M, et al. The global health and economic burden
of hospitalizations for heart failure: Lessons learned from hospitalized heart failure registries. J Am Coll Cardiol 2014; 63:
1123 – 1133.
2. Roger VL. Epidemiology of heart failure. Circ Res 2013; 113:
646 – 659.
3. Tanaka H, Nabeshima Y, Kitano T, Nagumo S, Tsujiuchi M,
Ebato M, et al. Optimal timing of echocardiography for heart
failure inpatients in Japanese institutions: OPTIMAL study.
ESC Heart Fail 2020; 7: 4213 – 4221.
4. Seo Y, Ishizu T, Ieda M, Ohte N, J-LONG Study Investigators.
Elderly Japanese standard data of echocardiography; From
Circulation Reports Vol.3, September 2021
Optimized Guideline-Based Therapy for Chronic HF
519
J-LONG study. J Echocardiogr 2020; 18: 175 – 182.
5. Blair JE, Zannad F, Konstam MA, Cook T, Traver B, Burnett
JC Jr, et al. Continental differences in clinical characteristics,
management, and outcomes in patients hospitalized with worsening
heart failure results from the EVEREST (Efficacy of Vasopressin
Antagonism in Heart Failure: Outcome Study with Tolvaptan)
program. J Am Coll Cardiol 2008; 52: 1640 – 1648.
6. Tsutsui H, Isobe M, Ito H, Ito H, Okumura K, Ono M, et al; on
behalf of the Japanese Circulation Society and the Japanese
Heart Failure Society Joint Working Group. JCS 2017/JHFS
2017 guideline on diagnosis and treatment of acute and chronic
heart failure: Digest version. Circ J 2019; 83: 2084 – 2184.
7. Bello NA, Claggett B, Desai AS, McMurray JJ, Granger CB,
Yusuf S, et al. Influence of previous heart failure hospitalization
on cardiovascular events in patients with reduced and preserved
ejection fraction. Circ Heart Fail 2014; 7: 590 – 595.
8. Akita K, Kohno T, Kohsaka S, Shiraishi Y, Nagatomo Y, Goda
A, et al. Prognostic impact of previous hospitalization in acute
heart failure patients. Circ J 2019; 83: 1261 – 1268.
9. Solomon SD, Dobson J, Pocock S, Skali H, McMurray JJ,
Granger CB, et al. Influence of nonfatal hospitalization for heart
failure on subsequent mortality in patients with chronic heart
failure. Circulation 2007; 116: 1482 – 1487.
10. Fujimoto W, Toh R, Takegami M, Hayashi T, Kuroda K, Hatani
Y, et al. Estimating incidence of acute heart failure syndromes in
Japan: An analysis from the KUNIUMI Registry. Circ J,
doi:10.1253/circj.CJ-20-1154.
11. McKee PA, Castelli WP, McNamara PM, Kannel WB. The
natural history of congestive heart failure: The Framingham
study. N Engl J Med 1971; 285: 1441 – 1446.
12. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A,
Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American
Society of Echocardiography and the European Association of
Cardiovascular Imaging. J Am Soc Echocardiogr 2015; 28: 1 – 39.e14.
13. Christ M, Stork S, Dorr M, Heppner HJ, Muller C, Wachter R,
et al. Heart failure epidemiology 2000 – 2013: Insights from the
German Federal Health Monitoring System. Eur J Heart Fail
2016; 18: 1009 – 1018.
14. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF,
Coats AJS, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the
Diagnosis and Treatment of Acute and Chronic Heart Failure of
the European Society of Cardiology (ESC) developed with the
special contribution of the Heart Failure Association (HFA) of
the ESC. Eur Heart J 2016; 37: 2129 – 2200.
15. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin
MM, et al. 2017 ACC/AHA/HFSA focused update of the 2013
ACCF/AHA guideline for the management of heart failure: A
report of the American College of Cardiology/American Heart
Association Task Force on Clinical Practice Guidelines and the
Heart Failure Society of America. Circulation 2017; 136: e137 – e161.
Akita K, Kohno T, Kohsaka S, Shiraishi Y, Nagatomo Y, Izumi
Y, et al. Current use of guideline-based medical therapy in elderly
patients admitted with acute heart failure with reduced ejection
fraction and its impact on event-free survival. Int J Cardiol 2017;
235: 162 – 168.
Dobre D, DeJongste MJ, Lucas C, Cleuren G, van Veldhuisen
DJ, Ranchor AV, et al. Effectiveness of beta-blocker therapy in
daily practice patients with advanced chronic heart failure; is
there an effect-modification by age? Br J Clin Pharmacol 2007;
63: 356 – 364.
Rossello X, Pocock SJ, Julian DG. Long-term use of cardiovascular drugs: Challenges for research and for patient care. J Am
Coll Cardiol 2015; 66: 1273 – 1285.
Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: Basic principles and practical
applications. Br J Clin Pharmacol 2004; 57: 6 – 14.
Jhund PS, Tavazzi L. Has the “epidemic” of heart failure been
replaced by a tsunami of co-morbidities? Eur J Heart Fail 2016;
18: 500 – 502.
Setoguchi S, Stevenson LW, Schneeweiss S. Repeated hospitalizations predict mortality in the community population with
heart failure. Am Heart J 2007; 154: 260 – 266.
McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP,
Rizkala AR, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 2014; 371: 993 – 1004.
McMurray JJV, Solomon SD, Inzucchi SE, Kober L, Kosiborod
MN, Martinez FA, et al. Dapagliflozin in patients with heart
failure and reduced ejection fraction. N Engl J Med 2019; 381:
1995 – 2008.
Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson
P, et al. Cardiovascular and renal outcomes with empagliflozin
in heart failure. N Engl J Med 2020; 383: 1413 – 1424.
Tsutsui H, Momomura SI, Yamashina A, Shimokawa H, Kihara
Y, Saito Y, et al. Efficacy and safety of ivabradine in Japanese
patients with chronic heart failure: J-SHIFT study. Circ J 2019;
83: 2049 – 2060.
Swedberg K, Komajda M, Bohm M, Borer JS, Ford I, DubostBrama A, et al. Ivabradine and outcomes in chronic heart failure
(SHIFT): A randomised placebo-controlled study. Lancet 2010;
376: 875 – 885.
Bristow MR, Gilbert EM, Abraham WT, Adams KF, Fowler
MB, Hershberger RE, et al. Carvedilol produces dose-related
improvements in left ventricular function and survival in subjects
with chronic heart failure. MOCHA Investigators. Circulation
1996; 94: 2807 – 2816.
Sin DD, McAlister FA. The effects of beta-blockers on morbidity
and mortality in a population-based cohort of 11,942 elderly
patients with heart failure. Am J Med 2002; 113: 650 – 656.
16. 17. 18. 19. 20. 21. 22. 23. 24. 25. 26. 27. 28. Circulation Reports Vol.3, September 2021
...
論文の公開元へ
